about
Sensory cortex underpinnings of traumatic brain injury deficitsRole of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/- miceGlutamate and taurine are increased in ventricular cerebrospinal fluid of severely brain-injured patientsThe tissue-type plasminogen activator-plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humansNedd4-WW domain-binding protein 5 (Ndfip1) is associated with neuronal survival after acute cortical brain injury.Rod microglia: a morphological definitionCCL2 modulates cytokine production in cultured mouse astrocytes.Measurement of serum melatonin in intensive care unit patients: changes in traumatic brain injury, trauma, and medical conditions.Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.Cytokines and neuropathology.Guilty molecules, guilty minds? The conflicting roles of the innate immune response to traumatic brain injuryErythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor.Post-traumatic hypoxia is associated with prolonged cerebral cytokine production, higher serum biomarker levels, and poor outcome in patients with severe traumatic brain injury.Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes.The role of markers of inflammation in traumatic brain injury.Monitoring the Neuroinflammatory Response Following Acute Brain Injury.Therapies negating neuroinflammation after brain trauma.Dual-modality NIRF-MRI cubosomes and hexosomes: High throughput formulation and in vivo biodistribution.Impact Acceleration Model of Diffuse Traumatic Brain Injury.Targeted therapeutic mild hypercapnia after cardiac arrest: A phase II multi-centre randomised controlled trial (the CCC trial).Markers for cell-mediated immune response are elevated in cerebrospinal fluid and serum after severe traumatic brain injury in humans.Nuclear trafficking of Pten after brain injury leads to neuron survival not death.Prolonged intrathecal release of soluble Fas following severe traumatic brain injury in humans.Characterising effects of impact velocity on brain and behaviour in a model of diffuse traumatic axonal injury.Endogenous melatonin increases in cerebrospinal fluid of patients after severe traumatic brain injury and correlates with oxidative stress and metabolic disarray.The scavenging chemokine receptor ACKR2 has a significant impact on acute mortality rate and early lesion development after traumatic brain injury.Erythropoietin Does Not Alter Serum Profiles of Neuronal and Axonal Biomarkers After Traumatic Brain Injury: Findings From the Australian EPO-TBI Clinical Trial.Deficiency of the chemokine receptor CXCR2 attenuates neutrophil infiltration and cortical damage following closed head injury.Thiopental attenuates energetic impairment but fails to normalize cerebrospinal fluid glutamate in brain-injured patients.Thiopental and midazolam do not seem to impede metabolism of glutamate in brain-injured patients.Cytomegalovirus production by infected astrocytes correlates with transforming growth factor-beta release.Thiopental in CSF and serum correlates with prolonged loss of cortical activity.Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury.Experimental diffuse axonal injury induces enhanced neuronal C5a receptor mRNA expression in rats.Environmental Enrichment Attenuates Traumatic Brain Injury: Induced Neuronal Hyperexcitability in Supragranular Layers of Sensory Cortex.Autocrine and paracrine regulation of astrocyte function by transforming growth factor-betaKupffer cells express type I TGF-beta receptors, migrate to TGF-beta and participate in streptococcal cell wall induced hepatic granuloma formationPenetration of cefuroxime into the cerebrospinal fluid of patients with traumatic brain injuryIL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function[New methods in polytrauma surgery. Results of a Study Congress at castle Reisenburg 27/28 February 2000]
P50
Q27328413-5A6C10FE-C57A-48B2-9217-0358F3799617Q28268523-0BC591E7-3B68-4B3E-969F-F079DE4E12F1Q28372597-691CEF72-3D72-4945-816F-84440DDAEF7AQ30528502-87E241D9-1B55-43C6-B4FB-8E1A478E41F7Q33249022-F5E9F9D1-871E-49BD-8C99-C24B6A53EAAAQ33618424-BC730DA0-B7FC-4253-8B48-194E96B553A2Q33618424-C214908C-138D-4B8A-B6D6-6FB79E5EE43CQ34243826-C4F9B852-E75C-454D-9B14-329BEBABB092Q34529724-ACDCC2AE-69D1-4C67-B72C-8D0FE56A14C3Q35689877-ACC190C1-7844-4D6F-9B87-C03F1FE97737Q35750398-F19E95B6-7226-4DDC-A28E-50CDE70CB889Q36026673-05C951D5-6B00-4793-8708-389E6F949C7AQ37496924-EF36C165-A61E-49CE-8E78-28F6061CB137Q37653695-F6F0AE07-77AC-4C36-B920-F24ED0B9F7A8Q37717276-F281E9E8-9FD3-4330-83E6-4EF73666BF3FQ38086443-76F7B389-6641-4EBD-A808-F7D6F9E2AF28Q38642078-7056D4EC-EBDF-47C5-8220-D9959C555FF9Q38689124-90BCD55C-8833-4C1E-9185-B3D34A11DF34Q38781503-24B391BC-93A3-4C47-94CD-002164C49BDBQ38948808-C679BC6B-1595-48F7-9B1E-865080F9CDFDQ40810000-698D1887-C897-4160-A898-C175592813B2Q43630456-B310549F-988C-4512-8006-43C0ABCA55D0Q43825562-2D3F644D-483B-4DCB-A86E-CCFC8F7B0F83Q43845631-B7677473-8357-4394-B80F-E36D72EEDC20Q45216491-275F2526-14FA-49EF-B45A-F5F4A17416EFQ46816949-31556409-2E9A-4146-9DA2-46CAB50BAA5AQ47140929-75D58AB6-76AE-460C-9440-9891BB6E491DQ47895367-80EC87CB-B03A-4015-8A69-5655A5BF54A8Q48132586-D572DA1B-15D5-48A8-8AA3-A3807A8BDE05Q48136939-63DD379C-1B28-433E-997A-291BBB18A1BEQ48287736-779B82CB-E3FB-4BF1-AAD4-61760F2E2C51Q48382115-F03FB471-55BA-45CD-B5FB-A3A889FA6DCCQ48443720-5FDC34C4-A00E-4EDE-B7D8-A122E1862598Q48515139-8284F1DF-328D-4E75-B678-5F7C911C2EE1Q48580972-B9AE0075-6846-4A0D-B9E2-A7843563B887Q49083664-C0C7EF28-4529-4973-BA97-BA6783A45A0AQ67491117-EBF34F70-AE73-49D1-B0EC-6245812A8F5BQ67494568-D93223D4-8AE3-4B20-86D9-A75BB4657550Q71119685-CCC79188-F8EC-4397-8DF2-27B79C45910FQ73225519-98C57D3F-26EE-4D7B-A189-50F88A28EC52
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maria Cristina Morganti-Kossmann
@ast
Maria Cristina Morganti-Kossmann
@en
Maria Cristina Morganti-Kossmann
@es
Maria Cristina Morganti-Kossmann
@nl
type
label
Maria Cristina Morganti-Kossmann
@ast
Maria Cristina Morganti-Kossmann
@en
Maria Cristina Morganti-Kossmann
@es
Maria Cristina Morganti-Kossmann
@nl
prefLabel
Maria Cristina Morganti-Kossmann
@ast
Maria Cristina Morganti-Kossmann
@en
Maria Cristina Morganti-Kossmann
@es
Maria Cristina Morganti-Kossmann
@nl
P106
P1153
56861164700
7004851184
P21
P31
P496
0000-0002-0807-2063